Search

Your search keyword '"Maurer, Gerald"' showing total 1,286 results
Start Over Author "Maurer, Gerald"
1,286 results on '"Maurer, Gerald"'

101. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

Author

Bonow, Robert O., Maurer, Gerald, Lee, Kerry L., Holly, Thomas A., Binkley, Philip F., Desvigne-Nickens, Patrice, Drozdz, Jaroslaw, Farsky, Pedro S., Feldman, Arthur M., Doenst, Torsten, Michler, Robert E., Berman, Daniel S., Nicolau, Jose C., Pellikka, Patricia A., Wrobel, Krzysztof, Alotti, Nasri, Asch, Federico M., Favaloro, Liliana E., She, Lilin, Velazquez, Eric J., Jones, Robert H., and Panza, Julio A.

Published
2011

107. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel

Author

Skulstad, Helge, primary, Cosyns, Bernard, primary, Popescu, Bogdan A, primary, Galderisi, Maurizio, primary, Salvo, Giovanni Di, primary, Donal, Erwan, primary, Petersen, Steffen, primary, Gimelli, Alessia, primary, Haugaa, Kristina H, primary, Muraru, Denisa, primary, Almeida, Ana G, primary, Schulz-Menger, Jeanette, primary, Dweck, Marc R, primary, Pontone, Gianluca, primary, Sade, Leyla Elif, primary, Gerber, Bernhard, primary, Maurovich-Horvat, Pal, primary, Bharucha, Tara, primary, Cameli, Matteo, primary, Magne, Julien, primary, Westwood, Mark, primary, Maurer, Gerald, primary, and Edvardsen, Thor, primary

Published
2020
Full Text
View/download PDF

108. Predictors of outcome in severe, asymptomatic aortic stenosis

Author

Rosenhek, Raphael, Binder, Thomas, Porenta, Gerold, Lang, Irene, Christ, Gunther, Schemper, Michael, Maurer, Gerald, and Baumgartner, Helmut

Subjects
Aortic valve stenosis -- Prognosis, Heart valve replacement -- Evaluation, Heart valve diseases -- Care and treatment
Abstract

Valvular calcification and increasing aortic-jet velocity are associated with poor prognoses in patients with aortic valve stenosis without symptoms. Results from a prospective study of 128 men and women revealed that 25% of those with mild aortic-valve calcification died or required surgery during four years, while 80% of those with moderate or greater calcification died or had valve surgery.

Published
2000

118. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

Author

Gyöngyösi, Mariann, Lang, Irene, Dettke, Markus, Beran, Gilbert, Graf, Senta, Sochor, Heinz, Nyolczas, Noémi, Charwat, Silvia, Hemetsberger, Rayyan, Christ, Günter, Édes, István, Balogh, László, Krause, Korff Thomas, Jaquet, Kai, Kuck, Karl-Heinz, Benedek, Imre, Hintea, Theodora, Kiss, Róbert, Préda, István, Kotevski, Vladimir, Pejkov, Hristo, Zamini, Sholeh, Khorsand, Aliasghar, Sodeck, Gottfried, Kaider, Alexandra, Maurer, Gerald, and Glogar, Dietmar

Published
2009

121. year 2020 in the European Heart Journal—Cardiovascular Imaging: part II.

Author

Cosyns, Bernard, Sade, Leyla Elif, Gerber, Bernhard L, Gimelli, Alessia, Muraru, Denisa, Maurer, Gerald, and Edvardsen, Thor

Subjects
ECHOCARDIOGRAPHY, HEART valve diseases, MITRAL valve insufficiency, CARDIOMYOPATHIES, TRICUSPID valve diseases, CARDIOVASCULAR diseases, DIAGNOSTIC imaging, PROSTHETIC heart valves, COMPUTED tomography, HEART failure, AORTIC valve
Abstract

The European Heart Journal—Cardiovascular Imaging was launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journal. The journal is now established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal from 2020 will be highlighted in two reports. Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. While Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

125. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

Author

Franchi, Francesco, James, Stefan, Ghukasyan, Tatevik, Budaj, Andrzej J., Cornel, Jan H., Katus, Hugo A., Keltai, Matyas, Kontny, Frederic, Lewis, Basil S., Storey, Robert F., Himmelmann, Anders, Wallentin, Lars, Angiolillo, Dominick J., Parkhomenko, Alexander Nikolaevich, Oto, Ali, Skene, Allan, Budaj, Andrzej, Freij, Anneli, Santoso, Anwar, Armando, A, Meier, Bernhard, Yu, Cheuk Man, Cannon, Christopher P., Zambahari, Dato Seri Robaayah, Wu, Delon Wu, Ardissino, Diego, Raev, Dimitar, Kremastinos, Dimitrios, Weaver, Douglas, Paolasso, Ernesto, Giannitsis, Evangelos, Verheugt, Freek, Maurer, Gerald, Katus, Hugo, Emanuelsson, Hakan, Horrow, Jay, Bassand, Jean-Pierre, Spinar, Jindrich, Morais, Joao, Lopez Sendon, Jose, Nicolau, Jose, Seung, Ki-Bae, Teik, Lim Soo, Heras, Magda, Claeys, Marc J., Sabatine, Marc, Vintila, Marius, Ruda, Mikhail, Thorsen, Mona, Kleiman, Neil, Babilonia, Noe, Commerford, Patrick, Gurbel, Paul, Aylward, Phil, Steg, Philippe Gabriel, Theroux, Pierre, Sritara, Piyamitr, Pais, Prem, Becker, Richard, Lassila, Riitta, Harrington, Robert A., Gao, Runlin, Husted, Steen, Duris, Tibor, Chapichadze, Zaza, HUS Comprehensive Cancer Center, University Management, Department of Oncology, and PLATO Investigators

Subjects
Male, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Comorbidity, 030204 cardiovascular system & hematology, urologic and male genital diseases, FUNCTION PROFILES, RESPONSIVENESS, Electrocardiography, 0302 clinical medicine, Risk Factors, Coronary Heart Disease, ARTERY-DISEASE, Medicine, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Myocardial infarction, Stroke, Original Research, Kardiologi, Absolute risk reduction, Diabetes, Type 2, DUAL ANTIPLATELET THERAPY, Middle Aged, Prognosis, Clopidogrel, female genital diseases and pregnancy complications, 3. Good health, Survival Rate, diabetes mellitus, Female, Cardiology and Cardiovascular Medicine, Ticagrelor, medicine.drug, Platelets, RENAL-FUNCTION, medicine.medical_specialty, Acute coronary syndrome, ANTITHROMBOTIC THERAPY, INHIBITION, acute coronary syndrome, ticagrelor, 03 medical and health sciences, Internal medicine, Diabetes mellitus, Humans, Renal Insufficiency, Chronic, Aged, Retrospective Studies, Pharmacology, clopidogrel, Dose-Response Relationship, Drug, business.industry, Thrombosis, medicine.disease, United States, REACTIVITY, 3121 General medicine, internal medicine and other clinical medicine, Purinergic P2Y Receptor Antagonists, Human medicine, business, Acute Coronary Syndromes, Platelet Aggregation Inhibitors, chronic kidney disease, Follow-Up Studies, Kidney disease
Abstract

Background There are limited data on how the combination of diabetes mellitus ( DM ) and chronic kidney disease ( CKD ) affects cardiovascular outcomes as well as response to different P2Y 12 receptor antagonists, which represented the aim of the present investigation. Methods and Results In this post hoc analysis of the PLATO (Platelet Inhibition and Patient Outcomes) trial, which randomized acute coronary syndrome patients to ticagrelor versus clopidogrel, patients (n=15 108) with available DM and CKD status were classified into 4 groups: DM +/ CKD + (n=1058), DM +/ CKD − (n=2748), DM −/ CKD + (n=2160), and DM −/ CKD − (n=9142). The primary efficacy end point was a composite of cardiovascular death, myocardial infarction, or stroke at 12 months. The primary safety end point was PLATO major bleeding. DM +/ CKD + patients had a higher incidence of the primary end point compared with DM −/ CKD − patients (23.3% versus 7.1%; adjusted hazard ratio 2.22; 95% CI 1.88–2.63; P DM +/ CKD − and DM −/ CKD + had an intermediate risk profile. The same trend was shown for the individual components of the primary end point and for major bleeding. Compared with clopidogrel, ticagrelor reduced the incidence of the primary end point consistently across subgroups ( P ‐interaction=0.264), but with an increased absolute risk reduction in DM +/ CKD +. The effects on major bleeding were also consistent across subgroups ( P ‐interaction=0.288). Conclusions In acute coronary syndrome patients, a gradient of risk was observed according to the presence or absence of DM and CKD , with patients having both risk factors at the highest risk. Although the ischemic benefit of ticagrelor over clopidogrel was consistent in all subgroups, the absolute risk reduction was greatest in patients with both DM and CKD . Clinical Trial Registration URL : http://www.clinicatrials.gov . Unique identifier: NCT 00391872.

Published
2019

131. Heterogeneous aortic response to acute [beta]-adrenergic blockade in Marfan syndrome

Author

Haouzi, Annick, Berglund, Hans, Pelikan, Peter C.D., Maurer, Gerald, and Siegel, Robert J.

Subjects
Medicine, Preventive, Preventive health services, Adrenergic beta blockers, Marfan syndrome, Cardiac patients, Health
Abstract

Byline: Annick Haouzi, Hans Berglund, Peter C.D. Pelikan, Gerald Maurer, Robert J. Siegel Abstract: Although prophylactic treatment with [beta]-blockers is used to retard aortic root dilatation in Marfan syndrome, it is not effective in all patients. To assess the effects of [beta]-adrenergic blockade on the aorta's elastic properties, aortic stiffness index and distensibility were calculated in 13 patients with Marfan syndrome and 10 control subjects before and after [beta]-adrenergic blockade. At baseline, patients with Marfan syndrome had a significantly increased stiffness index and decreased distensibility. After [beta]-adrenergic blockade, 8 patients with Marfan syndrome developed stiffness indexes and distensibility values that were closer to normal, whereas these variables deteriorated in 5 patients. Thus the benefit of [beta]-adrenergic blockade in Marfan syndrome may be the reduction in pulse pressure and myocardial contractility and also promotion of the elastic properties of the aorta. Moreover, the differential responses of aortic mechanics (normalizing or worsening) to [beta]-adrenergic blockade may possibly have implications for the prognosis in these patients. (Am Heart J 1997;133:60-3.) Author Affiliation: Vandoeuvre-les-Nancy, France, Los Angeles and Santa Monica, Calif., and Vienna, Austria Article History: Received 13 November 1995; Accepted 11 March 1996 Article Note: (footnote) [star] From the aDepartment of Cardiovascular Surgery, HA[acute accent]pital de Brabois; b Division of Cardiology, Cedars-Sinai Medical Center, and University of California, Los Angeles School of Medicine; the cPacific Heart Institute, St. Johns Hospital and Heart Center; and d Cardiology Department, University of Vienna., [star][star] Supported by grants from the Swedish Society of Medicine, Wenner-Gren Center Foundation, Swedish Institute, Einar Belven Foundation, Herbert Stein MD Research Fund, and Lee E. Siegel MD Memorial Fund, Western Cardiac Foundation., a Reprint requests: Hans Berglund, MD, Division of Cardiology, Room 5335, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048., aa 4/1/75315

Published
1997

136. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity

Author

Kopp, Christoph W., Hölzenbein, Thomas, Steiner, Sabine, Marculescu, Rodrig, Bergmeister, Helga, Seidinger, Daniela, Mosberger, Isabella, Kaun, Christoph, Cejna, Manfred, Horvat, Reinhard, Wojta, Johann, Maurer, Gerald, Binder, Bernd R., Breuss, Johannes M., Ecker, Rupert C., de Martin, Rainer, and Minar, Erich

Published
2004
Full Text
View/download PDF

138. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes : Insights From the PLATO Trial

Author

Franchi, Francesco, James, Stefan, Ghukasyan, Tatevik, Budaj, Andrzej J., Cornel, Jan H., Katus, Hugo A., Keltai, Matyas, Kontny, Frederic, Lewis, Basil S., Storey, Robert F., Himmelmann, Anders, Wallentin, Lars, Angiolillo, Dominick J., Parkhomenko, Alexander Nikolaevich, Oto, Ali, Skene, Allan, Budaj, Andrzej, Freij, Anneli, Santoso, Anwar, Armando, A, Meier, Bernhard, Yu, Cheuk Man, Cannon, Christopher P., Zambahari, Dato Seri Robaayah, Wu, Delon Wu, Ardissino, Diego, Raev, Dimitar, Kremastinos, Dimitrios, Weaver, Douglas, Paolasso, Ernesto, Giannitsis, Evangelos, Verheugt, Freek, Maurer, Gerald, Katus, Hugo, Emanuelsson, Hakan, Horrow, Jay, Bassand, Jean-Pierre, Spinar, Jindrich, Morais, Joao, Lopez Sendon, Jose, Nicolau, Jose, Seung, Ki-Bae, Teik, Lim Soo, Heras, Magda, Claeys, Marc J., Sabatine, Marc, Vintila, Marius, Ruda, Mikhail, Thorsen, Mona, Kleiman, Neil, Babilonia, Noe, Commerford, Patrick, Gurbel, Paul, Aylward, Phil, Steg, Philippe Gabriel, Theroux, Pierre, Sritara, Piyamitr, Pais, Prem, Becker, Richard, Lassila, Riitta, Harrington, Robert A., Gao, Runlin, Husted, Steen, Duris, Tibor, Chapichadze, Zaza, Franchi, Francesco, James, Stefan, Ghukasyan, Tatevik, Budaj, Andrzej J., Cornel, Jan H., Katus, Hugo A., Keltai, Matyas, Kontny, Frederic, Lewis, Basil S., Storey, Robert F., Himmelmann, Anders, Wallentin, Lars, Angiolillo, Dominick J., Parkhomenko, Alexander Nikolaevich, Oto, Ali, Skene, Allan, Budaj, Andrzej, Freij, Anneli, Santoso, Anwar, Armando, A, Meier, Bernhard, Yu, Cheuk Man, Cannon, Christopher P., Zambahari, Dato Seri Robaayah, Wu, Delon Wu, Ardissino, Diego, Raev, Dimitar, Kremastinos, Dimitrios, Weaver, Douglas, Paolasso, Ernesto, Giannitsis, Evangelos, Verheugt, Freek, Maurer, Gerald, Katus, Hugo, Emanuelsson, Hakan, Horrow, Jay, Bassand, Jean-Pierre, Spinar, Jindrich, Morais, Joao, Lopez Sendon, Jose, Nicolau, Jose, Seung, Ki-Bae, Teik, Lim Soo, Heras, Magda, Claeys, Marc J., Sabatine, Marc, Vintila, Marius, Ruda, Mikhail, Thorsen, Mona, Kleiman, Neil, Babilonia, Noe, Commerford, Patrick, Gurbel, Paul, Aylward, Phil, Steg, Philippe Gabriel, Theroux, Pierre, Sritara, Piyamitr, Pais, Prem, Becker, Richard, Lassila, Riitta, Harrington, Robert A., Gao, Runlin, Husted, Steen, Duris, Tibor, and Chapichadze, Zaza

Abstract

Background-There are limited data on how the combination of diabetes mellitus (DM) and chronic kidney disease (CKD) affects cardiovascular outcomes as well as response to different P2Y(12) receptor antagonists, which represented the aim of the present investigation. Methods and Results-In this post hoc analysis of the PLATO (Platelet Inhibition and Patient Outcomes) trial, which randomized acute coronary syndrome patients to ticagrelor versus clopidogrel, patients (n=15 108) with available DM and CKD status were classified into 4 groups: DM+/CKD+ (n=1058), DM+/CKD- (n=2748), DM-/CKD+ (n=2160), and DM-/CKD- (n=9142). The primary efficacy end point was a composite of cardiovascular death, myocardial infarction, or stroke at 12 months. The primary safety end point was PLATO major bleeding. DM+/CKD+ patients had a higher incidence of the primary end point compared with DM-/CKD- patients (23.3% versus 7.1%; adjusted hazard ratio 2.22; 95% CI 1.88-2.63; P<0.001). Patients with DM+/CKD- and DM-/CKD+ had an intermediate risk profile. The same trend was shown for the individual components of the primary end point and for major bleeding. Compared with clopidogrel, ticagrelor reduced the incidence of the primary end point consistently across subgroups (P-interaction=0.264), but with an increased absolute risk reduction in DM+/CKD+. The effects on major bleeding were also consistent across subgroups (P-interaction=0.288). Conclusions-In acute coronary syndrome patients, a gradient of risk was observed according to the presence or absence of DM and CKD, with patients having both risk factors at the highest risk. Although the ischemic benefit of ticagrelor over clopidogrel was consistent in all subgroups, the absolute risk reduction was greatest in patients with both DM and CKD.

Published
2019
Full Text
View/download PDF

139. year 2020 in the European Heart Journal – Cardiovascular Imaging: part I.

Author

Edvardsen, Thor, Donal, Erwan, Marsan, Nina A, Maurovich-Horvat, Pál, Dweck, Marc R, Maurer, Gerald, Petersen, Steffen E, and Cosyns, Bernard

Subjects
ECHOCARDIOGRAPHY, MYOCARDIUM, MYOCARDIAL ischemia, SERIAL publications, MAGNETIC resonance imaging, DIAGNOSTIC imaging
Abstract

The European Heart Journal – Cardiovascular Imaging was launched in 2012 and has during these 9 years become one of the leading multimodality cardiovascular imaging journals. The journal is currently ranked as number 20 among all cardiovascular journals. Our journal is well established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal in 2020 will be highlighted in two reports. Part I of the review will focus on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging, while Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

147. Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-[kappa]B pathway. (Major Article)

Author

Niessner, Alexander, Kaun, Christoph, Zorn, Gerlinde, Speidl, Walter, Turel, Zeynep, Christiansen, Gunna, Pedersen, Anna-Sofie, Birkelund, Svend, Simon, Susan, Georgopoulos, Apostolos, Graninger, Wolfgang, Martin, Rainer de, Lipp, Joachim, Binder, Bernd H., Maurer, Gerald, Huber, Kurt, and Wajta, Johann

Subjects
Blood circulation disorders -- Causes of, Blood circulation disorders -- Health aspects, Gene expression -- Physiological aspects, Interleukin-6 -- Physiological aspects, Interleukin-6 -- Genetic aspects, Endothelium -- Physiological aspects, Endothelium -- Genetic aspects, Chlamydia -- Physiological aspects, Chlamydia -- Health aspects, Membrane proteins -- Physiological aspects, Membrane proteins -- Genetic aspects, Airborne infection -- Research, Airborne infection -- Causes of, Health
Published
2003

Catalog

Books, media, physical & digital resources
See catalog results